U.S. Department of Health and Human Services
Peter Joseph Savage

 Contact Info

Tel: 301-496-5714
Email: peter.savage@nih.gov

 Select Experience

  • Clinical Trials Branch ChiefDivision of Epidemiology, NHLBI, NIH1986-2008
  • ChiefEndocrinology Section, and Associate Professor, VA Hospital,  Wayne State University School of Medicine1982-1986
  • Assistant ProfessorUniversity of Michigan School of Medicine1979-1982
  • Internal Medicine Residency/Endocrinology FellowshipYale University School of Medicine1968-1972
  • M.D. Tufts University School of Medicine1968

Peter J. Savage, M.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities & Activities

My current portfolio includes a multicenter study assessing different strategies to preserve or improve endogenous insulin secretion in individuals with prediabetes or the early stages of type 2 diabetes.   I hope to develop additional studies in this area. 

I also am the project official for the Diabetes, Endocrinology, and Metabolism R21 grant program (PA 12-125) and assist investigators interested in using existing research datasets for studies that answer a given question or provide preliminary data to help plan more extensive studies. 

In addition, I am the NIDDK representative on the NIH Comparative Effectiveness Research (CER) Coordinating Committee, a position that has involved me in CER studies and several ongoing efforts to enhance opportunities to take advantage of large data collections in HMOs or other large health care organizations with electronic health record systems to conduct large epidemiology studies or large simple clinical trials. 

In view of my previous experience as an endocrinologist at the National Heart Lung and Blood Institute, I remain interested in cardiovascular disease, especially the cardiovascular complications associated with diabetes, obesity, and renal disease. 

​Research Programs

Clinical Research in Type 1 Diabetes
This program supports clinical research that addresses the determinants, etiology, progression, prevention, and treatment of type 1 diabetes in children and adults

Clinical Research in Type 2 Diabetes
This program supports studies in humans aimed at the prevention, treatment, and diagnosis of type 2 diabetes across the lifespan, as well as further characterizing and understanding the mechanistic aspects of the etiology of type 2 diabetes

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of type 1 and type 2 diabetes

Current Committee Memberships

  • NIH CER Coordinating CommitteeNIDDK Representative
  • NIH Collaboratory Initiative Development Working GroupNIDDK Representative